Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group

G Moertel, C; Frytak, Stephen; G. Hahn, R.; J. OʼConnell, M.; J. Reitemeier, Richard; Rubin, Joan; J. Schutt, Allan; H. Weiland, L.; S. Childs, Donald; A. Holbrook, Margaret; T. Lavin, Philip; M. Livstone, Elliot; Spiro, Harry; H. Knowlton, Arthur; H. Kalser, Martin; S. Barkin, Jamie; E. Lessner, Howard; Kaplan, Richard; P. Ramming, Kenneth; O. Douglas, Harold; Thomas, P.; Nave, Heike; R. Bateman, Joseph; J. Lokich, Jacob; Renée Brooks, J.; T. Chaffey, John; M. Corson, Joseph; Zamcheck, Norman; W. Novak, Joel

doi:10.1002/1097-0142(19811015)48:8<1705::aid-cncr2820480803>3.0.co;2-4

Public

Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group

Published in Cancer • Oct 15, 1981

Authors:

C G Moertel

Stephen Frytak

R. G. Hahn

Abstract

One-hundred-ninety-four eligible and evaluable patients with histologically confirmed locally unresectable adenocarcinoma of the pancreas were randomly assigned to therapy with high-dose (6000 rads) radiation therapy alone, to moderate-dose (4000 rads) radiation + 5-fluorouracil (5-FU), and to high-...

Subject

Medicine

Fluorouracil

Radiation therapy

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!